指南与共识头颈甲状腺与浅表US

美国放射学会TI-RADS、韩国甲状腺放射学会TIRADS与美国甲状腺协会指南的性能特征比较

Comparison of Performance Characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association Guidelines.
指南 / 共识 · AJR Am J Roentgenol · 2018-04-09

该研究以3422个有病理结果的甲状腺结节为对象,比较ACR TI-RADS、KSThR TIRADS与ATA指南在细针穿刺或随访推荐上的表现。ACR TI-RADS无法分类结节比例为0%,活检恶性检出率14.2%,活检恶性结节占比68.2%,活检良性结节占比47.1%。结论认为ACR TI-RADS与其他成熟指南相比表现良好。

要点

  • ACR TI-RADS无法分类结节比例为0%,低于KSThR TIRADS的3.9%和ATA指南的13.9%。
  • ACR TI-RADS活检恶性检出率为14.2%,高于KSThR TIRADS的10.2%和ATA指南的10.0%。
  • ACR TI-RADS活检恶性结节占比68.2%,活检或随访恶性结节占比89.2%。

核心结论

  • ACR TI-RADS与其他成熟指南相比表现良好。

研究设计与样本

  • 研究比较ACR TI-RADS、KSThR TIRADS与ATA指南,使用3422个有病理结果的甲状腺结节。
  • 评估结节成分、回声、边缘、强回声灶和大小,判断各系统是否推荐细针穿刺或随访超声。
  • 对所有结节及≥1 cm结节,计算活检恶性检出率、随访检出率及活检恶性与良性结节百分比。

诊断标准与关键数值

  • 无法分类结节比例:ACR TI-RADS 0%,KSThR TIRADS 3.9%,ATA指南13.9%。
  • 活检恶性检出率:ACR TI-RADS 14.2%,KSThR TIRADS 10.2%,ATA指南10.0%。
  • 活检恶性结节占比:ACR TI-RADS 68.2%,KSThR TIRADS 78.7%,ATA指南75.9%。
  • 活检或随访恶性结节占比:ACR TI-RADS 89.2%。
  • 活检良性结节占比:ACR TI-RADS 47.1%,KSThR TIRADS 79.7%,ATA指南78.1%;ACR TI-RADS活检或随访良性结节占比65.2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) provides guidelines to practitioners who interpret sonographic examinations of thyroid nodules. The purpose of this study is to compare the ACR TI-RADS system with two other well-established guidelines.

MATERIALS AND METHODS: The ACR TI-RADS, the Korean Society of Thyroid Radiology (KSThR) Thyroid Imaging Reporting and Data System (TIRADS), and the American Thyroid Association guidelines were compared using 3422 thyroid nodules for which pathologic findings were available. The composition, echogenicity, margins, echogenic foci, and size of the nodules were assessed to determine whether a recommendation would be made for fine-needle aspiration or follow-up sonography when each system was used. The biopsy yield of malignant findings, the yield of follow-up, and the percentage of malignant and benign nodules that would be biopsied were determined for all nodules and for nodules 1 cm or larger.

RESULTS: The percentage of nodules that could not be classified was 0%, 3.9%, and 13.9% for the ACR TI-RADS, KSThR TIRADS, and ATA guidelines, respectively. The biopsy yield of malignancy was 14.2%, 10.2%, and 10.0% for nodules assessed by the ACR TI-RADS, KSThR TIRADS, and ATA guidelines, respectively. The percentage of malignant nodules that were biopsied was 68.2%, 78.7%, and 75.9% for the ACR TI-RADS, the KSThR TIRADS, and the ATA guidelines, respectively, whereas the percentage of malignant nodules that would be either biopsied or followed was 89.2% for the ACR TI-RADS. The percentage of benign nodules that would be biopsied was 47.1%, 79.7%, and 78.1% for the ACR TI-RADS, the KSThR TIRADS, and the ATA guidelines, respectively. The percentage of benign nodules that would be either biopsied or followed was 65.2% for the ACR TI-RADS.

CONCLUSION: The ACR TI-RADS performs well when compared with other well-established guidelines.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Middleton WD, Teefey SA, Reading CC, et al. Comparison of Performance Characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association Guidelines. AJR Am J Roentgenol. 2018. PMID: 29629797. doi:10.2214/AJR.17.18822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。